共 50 条
- [22] Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplantation, 2022, 57 : 1556 - 1563
- [23] Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1556 - 1563
- [25] Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (09): : 1391 - 1394
- [26] UNMANIPULATED GRAFT HAPLOINDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION (HAPLO-SCT) IN ACUTE LEUKEMIA: A LONG-TERM FOLLOW-UP SURVEY ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY (ALWP) OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT) BONE MARROW TRANSPLANTATION, 2014, 49 : S70 - S71